| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977204 | Brachytherapy | 2014 | 9 Pages |
Abstract
Modest dose escalation to the DIL (25-30%) using ultrasound-planned HDR brachytherapy is feasible for selected intermediate- and high-risk patients while respecting critical organ constraints and is achievable within the practice setting of a community cancer center.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Juanita Crook, Ana Ots, Miren Gaztañaga, Matt Schmid, Cynthia Araujo, Michelle Hilts, Deidre Batchelar, Brent Parker, François Bachand, Marie-Pierre Milette,